echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Immune cells in patients with amyotrophic lateral sclerosis can predict the course of the disease

    Immune cells in patients with amyotrophic lateral sclerosis can predict the course of the disease

    • Last Update: 2023-01-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    According to a study published in Nature Communications by the Karolinska Institutet, when diagnosing ALS, by measuring immune cells in the cerebrospinal fluid, it is possible to predict the rate of
    disease progression.

    Amyotrophic lateral sclerosis is a rare but fatal disease that affects nerve cells, leading to voluntary muscle paralysis and death
    .
    In a new study, researchers at the Karolinska Institute have discovered a way to
    predict the course of illness in ALS patients.

    Between March 2016 and March 2020, researchers collected fresh blood and cerebrospinal fluid
    from 89 patients in Stockholm who had recently been diagnosed with ALS.
    These patients were followed until October
    2020.

    Studies have shown that a high proportion of so-called effector T cells is associated with
    low survival.
    At the same time, a high proportion of activated regulatory T cells indicates a protective effect
    against rapid disease progression.
    The findings provide new evidence of T cell involvement in the disease process and suggest that certain types of effector T cells accumulate
    in the cerebrospinal fluid of ALS patients.

    Solmaz Yazdani, a PhD student at the Institute of Environmental Medicine at Karolinska Institute and first author of the study, said: "This research may help to develop new therapies that target immune cells to slow the progression of
    the disease.
    "

    The next step in her research is to study how T cells contribute to the development of
    the disease.

    "We plan to collect samples from these people to study how immune cells change
    over time.
    " In addition, we hope to study effector T cells in more detail to understand their role in
    ALS.

    The research was funded
    by the Ulla-Carin Lindquist ALS Research Foundation, the Department of Neurology, King Gustav V and the Queen Victoria Masonic Foundation, among others.

    Journal Reference:

    1. Solmaz Yazdani, Christina Seitz, Can Cui, Anikó Lovik, Lu Pan, Fredrik Piehl, Yudi Pawitan, Ulf Klä ppe, Rayomand Press, Kristin Samuelsson, Li Yin, Trung Nghia Vu, Anne-Laure Joly, Lisa S.
      Westerberg, Bjö rn Evertsson, Caroline Ingre, John Andersson, Fang Fang.
      T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression.
      Nature Communications, 2022; 13 (1) DOI: 10.
      1038/s41467-022-34526-9

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.